Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
12.18
+0.24 (2.01%)
At close: Dec 5, 2025, 4:00 PM EST
11.94
-0.24 (-1.97%)
After-hours: Dec 5, 2025, 7:51 PM EST
Amneal Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 3,829 | 2,454 | 1,861 | 301 | 715 | 675 | |
| Market Cap Growth | 46.42% | 31.88% | 517.29% | -57.87% | 6.05% | 4.38% | |
| Enterprise Value | 6,311 | 5,081 | 4,434 | 2,989 | 3,372 | 3,471 | |
| Last Close Price | 12.18 | 7.92 | 6.07 | 1.99 | 4.79 | 4.57 | |
| PE Ratio | 648.97 | - | - | - | 67.35 | 7.41 | |
| Forward PE | 14.38 | 11.69 | 11.92 | 2.71 | 5.65 | 7.07 | |
| PS Ratio | 1.30 | 0.88 | 0.78 | 0.14 | 0.34 | 0.34 | |
| PB Ratio | - | -55.10 | 30.35 | 1.44 | 1.86 | 1.89 | |
| P/FCF Ratio | 15.34 | 10.45 | 6.23 | 18.49 | 3.75 | 2.13 | |
| P/OCF Ratio | 11.68 | 8.32 | 5.38 | 4.63 | 2.96 | 1.78 | |
| PEG Ratio | - | 0.51 | 0.51 | 0.18 | 0.66 | 2.65 | |
| EV/Sales Ratio | 2.15 | 1.82 | 1.85 | 1.35 | 1.61 | 1.74 | |
| EV/EBITDA Ratio | 10.12 | 8.69 | 8.85 | 6.79 | 7.49 | 9.11 | |
| EV/EBIT Ratio | 16.46 | 14.59 | 16.34 | 14.94 | 15.57 | 23.83 | |
| EV/FCF Ratio | 25.28 | 21.64 | 14.84 | 183.29 | 17.67 | 10.94 | |
| Debt / Equity Ratio | -63.68 | -58.22 | 44.87 | 13.62 | 7.52 | 8.41 | |
| Debt / EBITDA Ratio | 4.17 | 4.28 | 5.26 | 6.15 | 6.15 | 7.36 | |
| Debt / FCF Ratio | 10.76 | 11.05 | 9.21 | 174.50 | 15.13 | 9.46 | |
| Asset Turnover | 0.83 | 0.80 | 0.66 | 0.57 | 0.53 | 0.52 | |
| Inventory Turnover | 3.04 | 2.98 | 2.75 | 2.79 | 2.67 | 3.08 | |
| Quick Ratio | 1.31 | 0.82 | 0.87 | 1.10 | 1.39 | 1.49 | |
| Current Ratio | 2.13 | 1.41 | 1.63 | 1.88 | 2.25 | 2.29 | |
| Return on Equity (ROE) | - | -881.26% | -36.06% | -85.96% | 5.45% | 19.50% | |
| Return on Assets (ROA) | 6.79% | 6.24% | 4.67% | 3.23% | 3.41% | 2.37% | |
| Return on Capital (ROIC) | 9.12% | 8.12% | 5.78% | 3.95% | 4.08% | 2.81% | |
| Return on Capital Employed (ROCE) | 14.00% | 14.70% | 10.30% | 6.60% | 6.60% | 4.40% | |
| Earnings Yield | 0.15% | -4.76% | -4.51% | -43.12% | 1.49% | 13.50% | |
| FCF Yield | 6.52% | 9.57% | 16.06% | 5.41% | 26.68% | 47.01% | |
| Buyback Yield / Dilution | -9.44% | -75.42% | -16.69% | 0.58% | -1.95% | -12.72% | |
| Total Shareholder Return | -9.44% | -75.42% | -16.69% | 0.58% | -1.95% | -12.72% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.